Dermata Therapeutics Files 8-K: Other Events Reported

Ticker: DRMAW · Form: 8-K · Filed: Sep 10, 2025 · CIK: 1853816

Dermata Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyDermata Therapeutics, Inc. (DRMAW)
Form Type8-K
Filed DateSep 10, 2025
Risk Levelmedium
Pages3
Reading Time3 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

Topics: 8-k, other-events

Related Tickers: DRMA

TL;DR

DRMA filed an 8-K for 'Other Events' on 9/10/25 - details TBD.

AI Summary

Dermata Therapeutics, Inc. filed an 8-K on September 10, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself. The company is incorporated in Delaware and its principal executive offices are located in San Diego, California.

Why It Matters

This filing indicates that Dermata Therapeutics has reported significant events to the SEC, but the lack of detail requires further investigation to understand the implications for the company.

Risk Assessment

Risk Level: medium — The filing is an 8-K for 'Other Events' without specific details, which creates uncertainty about the nature and impact of these events.

Key Players & Entities

  • Dermata Therapeutics, Inc. (company) — Registrant
  • September 10, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • San Diego, CA (location) — Address of principal executive offices
  • 001-40739 (identifier) — SEC File Number

FAQ

What specific 'Other Events' are being reported by Dermata Therapeutics, Inc. in this 8-K filing?

The filing does not specify the nature of the 'Other Events' beyond the general categorization.

What is the significance of the filing date being September 10, 2025?

September 10, 2025, is the date of the earliest event reported in this 8-K filing.

Where are Dermata Therapeutics, Inc.'s principal executive offices located?

The principal executive offices are located at 3525 Del Mar Heights Rd., #322, San Diego, CA 92130.

What is Dermata Therapeutics, Inc.'s state of incorporation?

Dermata Therapeutics, Inc. is incorporated in Delaware.

What is the SEC File Number for Dermata Therapeutics, Inc.?

The SEC File Number for Dermata Therapeutics, Inc. is 001-40739.

Filing Stats: 784 words · 3 min read · ~3 pages · Grade level 13.6 · Accepted 2025-09-10 08:00:53

Key Financial Figures

  • $0.0001 — ch Registered Common Stock, par value $0.0001 per share DRMA The Nasdaq Capital M

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DERMATA THERAPEUTICS, INC. Dated: September 10, 2025 By: /s/ Gerald T. Proehl Name: Gerald T. Proehl Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.